Search results for

We're discussing what's at stake for press freedom and the effects of the right-wing media machine spreading dangerous lies and conspiracy theories about the election.

According to a new ProPublica investigation, for years, America’s major gun-makers have shared their customer's personal information to win elections.

President Trump announced on Monday that Iran and Israel have agreed to a ceasefire, the U.S. Supreme Court allows third-country deportations temporarily, voting is underway in hotly contested New York City mayoral Democratic primary.

President Trump announced on social media on Monday that Iran and Israel had agreed to a ceasefire. That's after the U.S. got directly involved over the weekend striking key nuclear sites in Iran.

NPR's Michel Martin asks Rep. Jim Himes of Connecticut, top Democrat on the House Intelligence committee, about the Iranian attack on a U.S. airbase in Qatar.

With heat indices over 100 degrees across much of the country, it's hot out there. But is it too hot for kids to be outside?

Carol Moseley Braun is no stranger to stepping into new territory. She was the first Black woman elected to the U.S. Senate now she shares that experience a new memoir.

For weeks, federal prosecutors have laid out their case against Sean Combs in a Manhattan courtroom. His attorneys should begin presenting their defense on Tuesday. They aren't expected to take long.

Salvadoran journalist Mario Guevara is currently in Immigration and Customs Enforcement custody. The Committee to Protect Journalists warns his case represents an "erosion" of freedom of speech.

President Trump announced a ceasefire between Israel and Iran on Monday. But despite separate statements from the two countries saying they agreed to a truce, reports persisted of further airstrikes.

NPR's Michel Martin asks the Atlantic Council's Jonathan Panikoff whether a ceasefire agreement will stick between two countries that have spent decades antagonizing each other, Israel and Iran.

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.